Chronic stress is epidemic, and it is killing us. We know that and strive to become healthier. For some people that can be ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...